Biogen (BIIB) Deferred Taxes (2009 - 2026)
Biogen (BIIB) posted quarterly Deferred Taxes of -$27.6 million for Q2 2026, up 11.82% year-over-year from -$24.7 million in Q2 2025, and down 216.95% quarter-over-quarter from $23.6 million in Q1 2026.
Biogen (BIIB) Deferred Taxes (2009 - 2026) Analysis & Trends
Biogen's Deferred Taxes history runs 18 years deep, the most recent figure standing at -$27.6 million for Q2 2026.
- In Q2 2026, Deferred Taxes rose 11.82% year-over-year to -$27.6 million; the TTM figure through Jun 2026 stood at $416.7 million (up 344.97% YoY), while the FY2025 annual figure was $361.6 million, up 328.72% from the prior year.
- Deferred Taxes for Q2 2026 stood at -$27.6 million, down from $23.6 million in the prior quarter.
- The five-year high for Deferred Taxes was $253.8 million in Q3 2025, with the low at -$206.8 million in Q3 2023.
- The 5-year median for Deferred Taxes is -$30.0 million (2022), against an average of -$15.3 million.
- The sharpest annual moves came in 2023 and 2025: Deferred Taxes sank 6550.0% in 2023, then soared 582.51% in 2025.
- Biogen's Deferred Taxes stood at -$28.8 million in 2022, then jumped by 349.65% to $71.9 million in 2023, then sank by 181.22% to -$58.4 million in 2024, then soared by 385.79% to $166.9 million in 2025, then slumped by 116.54% to -$27.6 million in 2026.
- Business Quant data shows BIIB's Deferred Taxes at -$27.6 million in Q2 2026, $23.6 million in Q1 2026, and $166.9 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | -479.00 Mn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | -195.00 Mn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | -544.00 Mn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | - |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | -291.00 Mn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | -587.00 Mn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | -1.32 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | - |
| 10 | Biogen | 32.04 Bn | 30.76 Bn | 1.96 Bn | -27.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -27.60 Mn |
| Mar 31, 2026 | 23.60 Mn |
| Dec 31, 2025 | 166.90 Mn |
| Sep 30, 2025 | 253.80 Mn |
| Jun 30, 2025 | -31.30 Mn |
| Mar 31, 2025 | -27.80 Mn |
| Dec 31, 2024 | -58.40 Mn |
| Sep 30, 2024 | -52.60 Mn |
| Jun 30, 2024 | -87.00 Mn |
| Mar 31, 2024 | 39.90 Mn |
| Dec 31, 2023 | 71.90 Mn |
| Sep 30, 2023 | -206.80 Mn |
| Jun 30, 2023 | -106.40 Mn |
| Mar 31, 2023 | -64.50 Mn |
| Dec 31, 2022 | -28.80 Mn |
| Sep 30, 2022 | -92.30 Mn |
| Jun 30, 2022 | -48.50 Mn |
| Mar 31, 2022 | 1.00 Mn |
| Dec 31, 2021 | 323.30 Mn |
| Sep 30, 2021 | -127.30 Mn |